Publication | Open Access
177Lu-DOTATATE therapy in metastatic/inoperable pheochromocytoma-paraganglioma
50
Citations
19
References
2020
Year
177Lu-DOTATATE therapy is an effective and safe modality of treatment for patients with metastatic/inoperable PPGL. Although it is not prudent to withhold PRRT in metastatic PPGL with baseline SUVmax < 21, baseline SUVmax >21 can be used to predict early response to PRRT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1